CLL: Is There Still a Standard of Care? When it comes to treating CLL patients, is there still a standard of care? CLL experts Dr. John Burke and Dr. William Wierda discuss this topic with patient advocate Jeff Folloder. The panel explains the current approaches to standard treatment, the role of FCR (fludarabine, cyclophosphamide, rituximab) and the criteria used to start treatment. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |